<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Trihexyphenidyl for dystonia in cerebral palsy - Harvey, AR - 2018 | Cochrane Library</title> <meta content="Trihexyphenidyl for dystonia in cerebral palsy - Harvey, AR - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012430.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Trihexyphenidyl for dystonia in cerebral palsy - Harvey, AR - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012430.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012430.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Trihexyphenidyl for dystonia in cerebral palsy" name="citation_title"/> <meta content="Adrienne R Harvey" name="citation_author"/> <meta content="adrienne.harvey@rch.org.au" name="citation_author_email"/> <meta content="Louise B Baker" name="citation_author"/> <meta content="Dinah Susan Reddihough" name="citation_author"/> <meta content="Adam Scheinberg" name="citation_author"/> <meta content="Katrina Williams" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD012430.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/05/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012430.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012430.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012430.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Dyskinesia Agents [*therapeutic use]; Cerebral Palsy [*complications]; Dystonia [*drug therapy, etiology]; Trihexyphenidyl [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012430.pub2&amp;doi=10.1002/14651858.CD012430.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="4nUWI3Cc";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012430\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012430\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fr","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012430.pub2",title:"Trihexyphenidyl for dystonia in cerebral palsy",firstPublishedDate:"May 15, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Developmental, Psychosocial and Learning Problems Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=4nUWI3Cc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012430.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012430.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012430.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012430.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012430.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012430.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012430.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012430.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012430.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012430.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3361 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012430.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0093"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0062"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-sec-0087"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/appendices#CD012430-sec-0098"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/table_n/CD012430StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/table_n/CD012430StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Trihexyphenidyl for dystonia in cerebral palsy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#CD012430-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Adrienne R Harvey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#CD012430-cr-0003">Louise B Baker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#CD012430-cr-0004">Dinah Susan Reddihough</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#CD012430-cr-0005">Adam Scheinberg</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information#CD012430-cr-0006">Katrina Williams</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information/en#CD012430-sec-0122">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 May 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012430.pub2">https://doi.org/10.1002/14651858.CD012430.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012430-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012430-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012430-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012430-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012430-abs-0001" lang="en"> <section id="CD012430-sec-0001"> <h3 class="title" id="CD012430-sec-0001">Background</h3> <p>Cerebral palsy occurs in up to 2.1 of every 1000 live births and encompasses a range of motor problems and movement disorders. One commonly occurring movement disorder amongst those with cerebral palsy is dystonia: sustained or intermittent involuntary muscle spasms and contractions that cause twisting, repetitive movements and abnormal postures. The involuntary contractions are often very painful and distressing and cause significant limitations to activity and participation. </p> <p>Oral medications are often the first line of medical treatment for dystonia. Trihexyphenidyl is one such medication that clinicians often use to treat dystonia in people with cerebral palsy. </p> </section> <section id="CD012430-sec-0002"> <h3 class="title" id="CD012430-sec-0002">Objectives</h3> <p>To assess the effects of trihexyphenidyl in people with dystonic cerebral palsy, according to the World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF) domains of impairment, activity and participation. We also assessed the type and incidence of adverse effects in people taking the drug. </p> </section> <section id="CD012430-sec-0003"> <h3 class="title" id="CD012430-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, eight other databases and two trials registers in May 2017, and we checked reference lists and citations to identify additional studies. </p> </section> <section id="CD012430-sec-0004"> <h3 class="title" id="CD012430-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing oral trihexyphenidyl versus placebo for dystonia in cerebral palsy. We included studies in children and adults of any age with dystonic cerebral palsy, either in isolation or with the associated movement disorders of spasticity, ataxia, chorea, athetosis and/or hypotonia. We included studies regardless of whether or not the study authors specified the method used to diagnose dystonia in their study population. Primary outcomes were change in dystonia and adverse effects. Secondary outcomes were: activity, including mobility and upper limb function; participation in activities of daily living; pain; and quality of life. </p> </section> <section id="CD012430-sec-0005"> <h3 class="title" id="CD012430-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane.</p> </section> <section id="CD012430-sec-0006"> <h3 class="title" id="CD012430-sec-0006">Main results</h3> <p>We identified one study, which was set in Australia, that met the inclusion criteria. This was a randomised, double‐blind, placebo‐controlled, cross‐over trial in 16 children (10 boys and 6 girls) with predominant dystonic cerebral palsy and a mean age of 9 years (standard deviation 4.3 years, range 2 to 17 years). We considered the trial to be at low risk of selection, performance, detection, attrition, reporting and other sources of bias. We rated the GRADE quality of the evidence as low. </p> <p>We found no difference in mean follow‐up scores for change in dystonia as measured by the Barry Albright Dystonia Scale (BADS), which assesses eight body regions for dystonia on a 5‐point scale (0 = none to 4 = severe), resulting in a total score of 0 to 32. The BADS score was 2.67 points higher (95% confidence interval (CI) −2.55 to 7.90; low‐quality evidence), that is, worse dystonia, in the treated group. Trihexyphenidyl may be associated with an increased risk of adverse effects (risk ratio 2.54, 95% CI 1.38 to 4.67; low‐quality evidence). </p> <p>There was no difference in mean follow‐up scores for upper limb function as measured by the Quality of Upper Extremity Skills Test, which has four domains that collectively assess 36 items (each scored 1 or 2) and produces a total score of 0 to 100. The score in the treated group was 4.62 points lower (95% CI −10.98 to 20.22; low‐quality evidence), corresponding to worse function, than in the control group. We found low‐quality evidence for improved participation (as represented by higher scores) in the treated group in activities of daily living, as measured by three tools: 18.86 points higher (95% CI 5.68 to 32.03) for the Goal Attainment Scale (up to five functional goals scored on 5‐point scale (−2 = much less than expected to +2 = much more than expected)), 2.91 points higher (95% CI 1.01 to 4.82) for the satisfaction subscale of the Canadian Occupational Performance Measure (COPM; satisfaction with performance in up to five problem areas scored on a 10‐point scale (1 = not satisfied at all to 10 = extremely satisfied)), and 2.24 points higher (95% CI 0.64 to 3.84) for performance subscale of the COPM (performance in up to five problem areas scored on a 10‐point scale (1 = not able to do to; 10 = able to do extremely well)). </p> <p>The study did not report on pain or quality of life.</p> </section> <section id="CD012430-sec-0007"> <h3 class="title" id="CD012430-sec-0007">Authors' conclusions</h3> <p>At present, there is insufficient evidence regarding the effectiveness of trihexyphenidyl for people with cerebral palsy for the outcomes of: change in dystonia, adverse effects, increased upper limb function and improved participation in activities of daily living. The study did not measure pain or quality of life. There is a need for larger randomised, controlled, multicentre trials that also examine the effect on pain and quality of life in order to determine the effectiveness of trihexyphenidyl for people with cerebral palsy. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012430-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012430-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012430-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012430-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012430-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012430-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012430-abs-0004" lang="en"> <h3>Trihexyphenidyl for dystonia in cerebral palsy</h3> <p><b>Review question</b> </p> <p>Is trihexyphenidyl a helpful treatment for people with cerebral palsy who have a movement problem called dystonia? </p> <p><b>Background</b> </p> <p>Cerebral palsy is a common condition that covers a range of movement problems. One common movement problem is dystonia, which makes it difficult for people with cerebral palsy to control their movements. They have unwanted – and often painful and distressing – muscle contractions that they cannot control. The contractions reduce people's ability to move, perform self‐care activities, speak and participate in everyday activities. </p> <p>Doctors often use medications to treat this difficult condition, including trihexyphenidyl. However, all the benefits and harms of prescribing trihexyphenidyl for individuals with cerebral palsy and dystonia are still unknown. </p> <p><b>Study characteristics</b> </p> <p>In May 2017 we searched for all clinical trials that investigated the effectiveness of trihexyphenidyl for people with dystonic cerebral palsy. We included one Australian trial that involved 16 children (10 boys, 6 girls) with cerebral palsy and dystonia. They had an average age of nine years. </p> <p>The children were divided into two different groups. Both groups took 12 weeks of trihexyphenidyl and 12 weeks of a placebo (something that looks the same as trihexyphenidyl but with no active ingredient), with a 4‐week break in between during which they received neither. The only difference between the groups was that one group started with trihexyphenidyl and then had placebo, and the other group started with placebo and then had trihexyphenidyl. </p> <p><b>Key results</b> </p> <p>We found no evidence that trihexyphenidyl was effective for reducing dystonia or improving upper arm function in children with cerebral palsy and dystonia. Trihexyphenidyl may be associated with an increased risk of side effects (agitation, constipation, dry mouth and poor sleep). There was some evidence that trihexyphenidyl may improve individual goals set by the child and family around improved participation in activities of daily living. The study did not measure pain or quality of life. </p> <p><b>Quality of the evidence</b> </p> <p>We rated the quality of the evidence as low because the one study included a small number of children and there are no other studies to support the findings. Therefore, we are uncertain about the effectiveness of trihexyphenidyl in reducing dystonia or improving arm function and participation in everyday activities of people with cerebral palsy and dystonia. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012430-sec-0093" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-sec-0093">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-sec-0168">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012430-sec-0093"></div> <h3 class="title" id="CD012430-sec-0094">Implications for practice</h3> <section id="CD012430-sec-0094"> <p>At present, there is insufficient evidence to know whether or not trihexyphenidyl is an effective treatment for dystonia for people with cerebral palsy. We found no evidence to suggest that trihexyphenidyl reduces dystonia or improves upper limb function. We found evidence of a high risk of adverse effects, which is consistent with non‐trial evidence and use for other indications. Trihexyphenidyl may improve individual goals set by the child and family with regards to participation in activities of daily living. RCTs have not examined the effect of trihexyphenidyl on reducing pain or improving quality of life. Clinicians and consumers should be aware of the lack of evidence about effectiveness and the high risk of adverse effects before prescribing or taking this medication for dystonia in cerebral palsy. This would not preclude cautious use for individual indications with careful monitoring and slow dose escalation so that clinicians can assess risks and benefits for each individual. </p> </section> <h3 class="title" id="CD012430-sec-0095">Implications for research</h3> <section id="CD012430-sec-0095"> <p>The current evidence for trihexyphenidyl in people with cerebral palsy consists of only one RCT with a small sample size. There is an urgent need for larger RCTs of longer duration that also examine the effect on pain and quality of life in order to ascertain the effectiveness of trihexyphenidyl for dystonia in people with cerebral palsy. Researchers might also consider using lower‐dosing regimens to reduce the possible adverse effects of the medication, as well as using more sensitive outcome measures for dystonia, such as the Dyskinesia Impairment Scale (<a href="./references#CD012430-bbs2-0026" title="MonbaluiE , OrthibusE , deCatJ , DanB , HeyrmanL , PrinzieP , et al. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy. Developmental Medicine &amp; Child Neurology2012;54(3):278–83. [PUBMED: 22428172] ">Monbaliu 2012</a>). Although dystonia is a movement disorder seen frequently in children with cerebral palsy, it is not as common as spasticity. Therefore, multicentre trials are required in order to conduct adequately powered RCTs. In addition, taking into account the considerable heterogeneity in clinical presentation and management strategies seen in children with cerebral palsy, single‐agent RCTs may not be the most appropriate trial design. Other innovative trial designs may address clinical and research questions more appropriately. As neuroimaging advances our understanding of the types of brain injury an individual with dystonic cerebral palsy has, trial developers should consider brain injury type as a potential effect modifier and plan their methods accordingly. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012430-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012430-sec-0029"></div> <div class="table" id="CD012430-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: Trihexyphenidyl compared with placebo for dystonia in cerebral palsy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Trihexyphenidyl compared with placebo for dystonia in cerebral palsy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: children with dystonic cerebral palsy </p> <p><b>Settings</b>: one tertiary care hospital </p> <p><b>Intervention</b>: trihexyphenidyl </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Trihexyphenidyl</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in dystonia from baseline</b> </p> <p>Measured by: BADS (eight body regions assessed for dystonia on a five‐point scale (0 = none to 4 = severe), minimum score 0 to maximum score 32; higher score = greater severity of dystonia) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 15.50 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was <b>2.67 points higher</b> (2.55 lower to 7.90 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects<sup>b</sup> (mood disturbance, irritability, behavioural change, constipation)</b> </p> <p>Measured by: counts of number and type</p> <p>Follow‐up: various (includes data assessed at both 12 and 28 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.54 (1.38 to 4.67)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participation in activities of daily living</b> :<b>individual goal setting</b> </p> <p>Measured by: GAS (up to 5 functional goals scored on a 5‐point scale (−2 = much less than expected to +2 = much more than expected); higher score = better than expected outcome) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 27.63 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was <b>18.86 points higher</b> (5.68 higher to 32.03 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participation in activities of daily living</b> :<b>satisfaction with individual goals</b> </p> <p>Measured by: satisfaction subscale of the COPM (satisfaction with performance in up to 5 problem areas scored on a 10‐point scale (1 = not satisfied at all to 10 = extremely satisfied); higher score = greater satisfaction) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 2.96 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was <b>2.91 points higher</b> (1.01 higher to 4.82 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participation in activities of daily living</b> :<b>performance of individual goals</b> </p> <p>Measured by: performance subscale of the COPM (up to five problem areas scored on a 10‐point scale (1 = not able to do to 10 = able to do extremely well; higher score = better performance) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 3.14 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was<b>2.24 points higher</b> (0.64 higher to 3.84 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in the footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>BADS</b> : Barry Albright Dystonia Scale; <b>CI</b> : Confidence interval; <b>COPM</b> : Canadian Occupational Performance Measure; <b>GAS</b> : Goal Attainment Scale; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality</b> : we are very confident that the true effect lies close to that of the estimate of effect<br/> <b>Moderate quality</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different<br/> <b>Low quality</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of effect<br/> <b>Very low quality</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to imprecision; small sample size from one study only.<br/> <sup>b</sup>All side effects were counted as adverse effects, as defined in our protocol (<a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>). Adverse effect data was from both phases. It was not possible to obtain adverse effect data from the first phase only. All children were reported to have adverse effects in the treatment phase. Six out of 16 participants were reported to have adverse effects in the placebo phase; however, the timing of these is not clear. The estimated number of adverse effects in the placebo phase may therefore be lower and we may be underestimating the relative risk. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012430-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-sec-0130">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012430-sec-0030"></div> <section id="CD012430-sec-0031"> <h3 class="title" id="CD012430-sec-0031">Description of the condition</h3> <p>Cerebral palsy has been described as "a group of permanent disorders of the development of movement and posture, causing activity limitation ... [attributable] to non‐progressive disturbances that occurred in the developing fetal or infant brain" (<a href="./references#CD012430-bbs2-0034" title="RosenbaumP , PanethN , LevitonA , GoldsteinM , BaxM , DamianoD , et al. A report: the definition and classification of cerebral palsy April 2006. Developmental Medicine &amp; Child Neurology2007;49(109 Suppl):8‐14. [DOI: 10.1111/j.1469‐8749.2007.tb12610.x; PUBMED: 17370477] ">Rosenbaum 2007</a>). Disturbances of sensation, perception, cognition, communication and behaviour, epilepsy and secondary musculoskeletal problems often accompany the motor disorders of cerebral palsy. </p> <p>Cerebral palsy is a common childhood condition, occurring in approximately 2.11 of every 1000 live births (<a href="./references#CD012430-bbs2-0029" title="OskouiM , CoutinhoF , DykemanJ , JettéN , PringsheimT . An update on the prevalence of cerebral palsy: a systematic review and meta‐analysis. Developmental Medicine &amp; Child Neurology2013;55(6):509‐19. [DOI: 10.1111/dmcn.12080; PUBMED: 23346889] ">Oskoui 2013</a>). It encompasses motor problems such as spasticity (increased muscle tone); hyperkinetic disorders, such as dystonia and choreoathetosis where there is unwanted excessive movement; and, less commonly, ataxia (uncoordinated movement). However, many children present with a mixed movement disorder. </p> <p>Dystonia frequently occurs in children with cerebral palsy and is "characterised by involuntary sustained or intermittent muscle contractions that cause twisting and repetitive movements, abnormal postures, or both” (<a href="./references#CD012430-bbs2-0035" title="SangerTD , DelgadoMR , Gaebler‐SpiraD , HallettM , MinkJW , Task Force on Childhood Motor Disorders. Classification and definition of disorders causing hypertonia in childhood. Pediatrics2003;111(1):e89‐97. [DOI: 10.1542/peds.111.1.e89; PUBMED: 12509602] ">Sanger 2003</a>). Of the methods used to diagnose dystonia, the one with the greatest credibility is the Hypertonia Assessment Tool (HAT; <a href="./references#CD012430-bbs2-0021" title="JethwaA , MinkJ , MacArthurC , KnightsS , FehlingsT , FehlingsD . Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children. Developmental Medicine &amp; Child Neurology2010;52(5):e83‐7. [PUBMED: 20540176] ">Jethwa 2010</a>). The HAT is a seven‐item, standardised clinical assessment tool for children over four years of age, which is used to reliably differentiate the various types of paediatric hypertonia, namely spasticity, dystonia and rigidity (<a href="./references#CD012430-bbs2-0021" title="JethwaA , MinkJ , MacArthurC , KnightsS , FehlingsT , FehlingsD . Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children. Developmental Medicine &amp; Child Neurology2010;52(5):e83‐7. [PUBMED: 20540176] ">Jethwa 2010</a>). Dystonia can result from an abnormality in the basal‐ganglia cortical pathway and can be measured clinically using a variety of scales. It may affect one or more limbs, or be present throughout the child’s whole body, including the mouth, eyes and neck. The involuntary contractions are often very painful and distressing. Dystonia can reduce activity and participation across many of the health‐related domains described in the World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF) model (<a href="./references#CD012430-bbs2-0040" title="World Health Organisation (WHO). International Classification of Functioning, Disability and Health (ICF). www.who.int/classifications/icf/en/ (accessed 3 March 2016). ">WHO ICF 2003</a>). </p> <p>The percentage of children with cerebral palsy identified as having dominant dyskinetic cerebral palsy (including dystonia and choreoathetosis) is substantial, ranging from 6% in Australia to 15% in Europe (<a href="./references#CD012430-bbs2-0003" title="Australian Cerebral Palsy Register Group. Australia and the Australian Cerebral Palsy Register for the birth cohort 1993 to 2006. Developmental Medicine &amp; Child Neurology2016;58(S2):3‐4. [DOI: 10.1111/dmcn.13002; PUBMED: 26806361] ">ACPR 2016</a>; <a href="./references#CD012430-bbs2-0006" title="BaxM , TydemanC , FlodmarkO . Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA2006;296(13):1602‐8. [DOI: 10.1001/jama.296.13.1602; PUBMED: 17018805] ">Bax 2006</a>; <a href="./references#CD012430-bbs2-0019" title="HimmelmannK , HagbergG , WiklundLM , EekMN , UvebrantP . Dyskinetic cerebral palsy: a population‐based study of children born between 1991 and 1998. Development Medicine &amp; Child Neurology2007;49(4):246‐51. [DOI: 10.1111/j.1469‐8749.2007.00246.x; PUBMED: 17376133 ] ">Himmelmann 2007</a>). Children who are accurately identified as spasticity‐dominant can also have dyskinesia, which can add to their disability and discomfort. Traditionally, identifying dystonia and differentiating it from spasticity relied primarily on clinical examination and observation, with uncertain reliability and validity. The accurate identification of dyskinesia in children with cerebral palsy has been facilitated by the development of the HAT, which reliably differentiates the subtypes of hypertonia (<a href="./references#CD012430-bbs2-0021" title="JethwaA , MinkJ , MacArthurC , KnightsS , FehlingsT , FehlingsD . Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children. Developmental Medicine &amp; Child Neurology2010;52(5):e83‐7. [PUBMED: 20540176] ">Jethwa 2010</a>). </p> <p>Dystonia can have devastating effects on function, including impairment of communication and swallowing, and it can create difficulties in completing self‐care tasks and being comfortably seated in a wheelchair. Children also get into cycles of dystonia causing musculoskeletal pain, which in turn exacerbates their dystonia. The worst example of this is the dystonic crisis, which can require muscle paralysis/sedation (<a href="./references#CD012430-bbs2-0004" title="AllenNM , LinJ‐P , LynchT , KingMD . Status dystonicus: a practice guide. Developmental Medicine &amp; Child Neurology2014;56(2):105–12. [DOI: 10.1111/dmcn.12339; PUBMED: 24304390] ">Allen 2014</a>). These difficulties can negatively affect the quality of life of the individual and their caregivers. </p> </section> <section id="CD012430-sec-0032"> <h3 class="title" id="CD012430-sec-0032">Description of the intervention</h3> <p>Dystonia is a difficult movement disorder with limited management options available for treatment. Oral medications are often the first‐line of treatment for this challenging condition. </p> <p>Trihexyphenidyl (also known as benzhexol) is a selective muscarinic acetylcholine receptor antagonist, blocking cholinergic activity centrally and peripherally (<a href="./references#CD012430-bbs2-0028" title="National Institutes of Health (NIH). Trihexyphenidyl. pubchem.ncbi.nlm.nih.gov/compound/trihexyphenidyl (accessed prior to 19 April 2018). ">NIH 2005</a>). It is also thought to increase the availability of dopamine, a brain chemical that is critical in the initiation and smooth control of voluntary muscle movement. Trihexyphenidyl is available in liquid form, as a tablet, or as an extended‐release (long‐acting) capsule. The onset of action of this medication occurs within an hour of oral administration. It has a peak effect 2 to 3 hours after administration, and the duration of action can last from 6 to 12 hours. </p> </section> <section id="CD012430-sec-0033"> <h3 class="title" id="CD012430-sec-0033">How the intervention might work</h3> <p>The pathophysiology of dystonia involves a dysfunction in the basal ganglia. The pathways between the basal ganglia and the cortex are influenced by neurotransmitters that act on various receptors in feedback loops causing positive or negative effects. The mechanism of action of trihexyphenidyl in reducing dystonia is believed to be in the basal ganglia where it reduces acetylcholine and increases dopamine (<a href="./references#CD012430-bbs2-0008" title="Carranza‐del RioJ , CleggNJ , MooreA , DelgadoMR . Use of trihexyphenidyl in children with cerebral palsy. Pediatric Neurology2011;44(3):202‐6. [DOI: 10.1016/j.pediatrneurol.2010.09.008; PUBMED: 21310336] ">Carranza del Rio 2011</a>). By treating dystonia and its associated impairments, clinicians hope to improve activity and decrease associated pain and discomfort. </p> </section> <section id="CD012430-sec-0034"> <h3 class="title" id="CD012430-sec-0034">Why it is important to do this review</h3> <p>Medication is frequently used for dystonia but little information is available as to whether it is effective, and side effects are common. Most of the published studies assessing medications are small and descriptive, limiting the ability to draw conclusions on its effects. Prospective case series, such as <a href="./references#CD012430-bbs2-0036" title="SangerTD , BastianA , BrunstromJ , DamianoD , DelgadoM , Dure , L , et al. Prospective open‐label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. Journal of Child Neurology2007;22(5):530‐7. [DOI: 10.1177/0883073807302601; PUBMED: 17690057] ">Sanger 2007</a>, along with a few retrospective case series, like <a href="./references#CD012430-bbs2-0007" title="Ben‐PaziH . Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. Journal of Child Neurology2011;26(7):810‐6. [DOI: 10.1177/0883073810392582; PUBMED: 21498790] ">Ben‐Pazi 2011,</a> and <a href="./references#CD012430-bbs2-0020" title="HoonAHJr , FreesePO , ReinhardtEM , WilsonMA , LawrieWTJr , HarrymanSE , et al. Age‐dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatric Neurology2001;25(1):55‐58. [PUBMED: 11483397] ">Hoon 2001</a>, have reported inconsistent results for trihexyphenidyl in cerebral palsy; however, there is a need to examine evidence from existing randomised trials. This review will bring together and evaluate existing trials to clarify the benefits and risks of trihexyphenidyl for dystonia in cerebral palsy. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012430-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-sec-0135">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012430-sec-0035"></div> <p>To assess the effects of trihexyphenidyl in people with dystonic cerebral palsy, according to the World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF) domains of impairment, activity and participation. We also assessed the type and incidence of adverse effects in people taking the drug. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012430-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-sec-0136">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012430-sec-0036"></div> <section id="CD012430-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012430-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs).</p> </section> <section id="CD012430-sec-0039"> <h4 class="title">Types of participants</h4> <p>Children and adults with dystonic cerebral palsy, either in isolation or with the associated movement disorders of spasticity, ataxia, chorea, athetosis and/or hypotonia were eligible. Although we applied no age restrictions, we found no studies reporting outcomes for adults. </p> <p>We included studies regardless of whether or not the study authors specified the method used to diagnose dystonia in their study population. We did this in order to include all studies with relevant findings. We do concede, however, that studies using the HAT may have greater credibility than those using other or unspecific methods of diagnosis (<a href="./references#CD012430-bbs2-0021" title="JethwaA , MinkJ , MacArthurC , KnightsS , FehlingsT , FehlingsD . Development of the Hypertonia Assessment Tool (HAT): a discriminative tool for hypertonia in children. Developmental Medicine &amp; Child Neurology2010;52(5):e83‐7. [PUBMED: 20540176] ">Jethwa 2010</a>). </p> </section> <section id="CD012430-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Oral trihexyphenidyl, regardless of dosage or frequency of administration, used to treat dystonia in cerebral palsy. </p> <p>The control group had to be a placebo group. Trials with more than one comparison group were eligible, as long as one group received trihexyphenidyl and one group received placebo. </p> </section> <section id="CD012430-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD012430-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD012430-list-0001"> <li> <p>*Change in dystonia from baseline, as assessed using the Barry‐Albright Dystonia scale (<a href="./references#CD012430-bbs2-0005" title="BarryMJ , VanSwearingenJM , AlbrightAL . Reliability and responsiveness of the Barry‐Albright Dystonia Scale. Developmental Medicine &amp; Child Neurology1999;41(6):404‐11. [DOI: 10.1111/j.1469‐8749.1999.tb00626.x; PUBMED: 10400175] ">Barry 1999</a>), Dyskinesia Impairment Scale (<a href="./references#CD012430-bbs2-0026" title="MonbaluiE , OrthibusE , deCatJ , DanB , HeyrmanL , PrinzieP , et al. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy. Developmental Medicine &amp; Child Neurology2012;54(3):278–83. [PUBMED: 22428172] ">Monbaliu 2012</a>), or electrophysiological measures of dystonia </p> </li> <li> <p>*Adverse effects (mood disturbance, irritability, behavioural change, constipation)</p> </li> </ol> </p> </section> <section id="CD012430-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD012430-list-0002"> <li> <p>Activity, including mobility and upper limb function, as measured by validated scales such as the Canadian Occupational Performance Measure (<a href="./references#CD012430-bbs2-0023" title="LawMC , BaptiseS , CarswellA , McCollMA , PolatajkoH , PollockN . Canadian Occupational Performance Measure. 4th Edition. Ottawa (ON): CAOT Publications Ace, 2005. ">Law 2005</a>), Global Assessment Scale (<a href="./references#CD012430-bbs2-0011" title="EndicottJ , SpitzerRL , Fleiss , JL , CohenJ . The Global Assessment Scale. A procedure for measuring overall severity psychiatric disturbance. Archives of General Psychiatry1976;33(6):766‐71. [DOI: 10.1001/archpsyc.1976.01770060086012; PUBMED: 938196] ">Endicott 1976</a>), Quality of Upper Extremity Skills Test (<a href="./references#CD012430-bbs2-0031" title="DeMatteoC , LawM , RussellD , PollockN , RosenbaumP , WalterS . QUEST: Quality of Upper Extremity Skills Test. Hamilton (ON): McMaster University, CanChild Centre for Childhood Disability Research, 1992. ">QUEST 1992</a>), Melbourne Assessment of Unilateral Upper Limb Function (<a href="./references#CD012430-bbs2-0032" title="RandallMJ , JohnsonLM , ReddihoughDS . The Melbourne Assessment of Unilateral Upper Limb Function: Test Administration Manual. Melbourne (AU): Royal Children's Hospital, 1999. ">Randall 1999</a>), Gross Motor Function Measure (<a href="./references#CD012430-bbs2-0015" title="HannaSE , BartlettDJ , RivardLM , RussellDJ . Reference curves for the Gross Motor Function Measure: percentiles for clinical description and tracking over time among children with cerebral palsy. Physical Therapy2008;88(5):596‐607. [DOI: 10.2522/ptj.20070314; PMC2390723; PUBMED: 18339799] ">Hanna 2008</a>), Three Dimensional Gait Analysis (<a href="./references#CD012430-bbs2-0012" title="FerberR . 3‐D Gait. www.3dgaitanalysis.com/3d‐gait/ (accessed 3 March 2016). ">Ferber 2016</a>), Timed Up and Go Test (<a href="./references#CD012430-bbs2-0038" title="NgSS , Hui‐ChanCW . The Timed Up &amp; Go Test: its reliability and association with lower‐limb impairments and locomotor capacities in people with chronic stroke. Archives of Physical Medicine and Rehabilitation2005;86(8):1641–7. [DOI: 10.1016/j.apmr.2005.01.011; PUBMED: 16084820 ] ">TUG 2005</a>), Functional Independence Measure (<a href="./references#CD012430-bbs2-0039" title="MsallME , DiGaudioK , RogersBT , LaForestS , CatanzaroNL , CampbellJ , et al. The Functional Independence Measure for Children (WeeFIM). Conceptual basis and pilot use in children with developmental disabilities. Clinical Pediatrics1994;33(7):421‐30. [DOI: 10.1177/000992289403300708; PUBMED: 7525140] ">WeeFIM 1994</a>), and High‐level Mobility Assessment Tool (<a href="./references#CD012430-bbs2-0041" title="WilliamsG . Introduction to the High Level Mobility Assessment Tool. www.tbims.org/combi/himat/ (accessed 3 March 2016). ">Williams 2006</a>) </p> </li> <li> <p>*Participation in activities of daily living at home, school, in the community and in the workforce, as measured by validated scales such as the Children's Assessment of Participation and Enjoyment (<a href="./references#CD012430-bbs2-0022" title="KingG , LawM , KingS , HurleyP , HannaS , KertoyM , et al. Children's Assessment of Participation and Enjoyment (CAPE) and Preferences for Activities of Children (PAC). San Antonio (TX): Harcourt Assessment, Inc, 2004. ">King 2004</a>), the Canadian Occupational Performance Measure (<a href="./references#CD012430-bbs2-0023" title="LawMC , BaptiseS , CarswellA , McCollMA , PolatajkoH , PollockN . Canadian Occupational Performance Measure. 4th Edition. Ottawa (ON): CAOT Publications Ace, 2005. ">Law 2005</a>), and the Global Assessment Scale (<a href="./references#CD012430-bbs2-0011" title="EndicottJ , SpitzerRL , Fleiss , JL , CohenJ . The Global Assessment Scale. A procedure for measuring overall severity psychiatric disturbance. Archives of General Psychiatry1976;33(6):766‐71. [DOI: 10.1001/archpsyc.1976.01770060086012; PUBMED: 938196] ">Endicott 1976</a>) </p> </li> <li> <p>Pain, as measured by validated scales such as the Wong‐Baker FACES Pain Rating Scale (<a href="./references#CD012430-bbs2-0042" title="The Wong‐Baker FACES Foundation. Wong‐Baker FACES® Pain Rating Scale. wongbakerfaces.org/ (accessed 3 March 2016). ">Wong‐Baker FACES Pain Rating Scale 2001</a>) </p> </li> <li> <p>*Quality of life, as measured by validated scales such as the Pediatric Quality of Life Inventory (<a href="./references#CD012430-bbs2-0030" title="VarniJW , SeidM , RodeCA . The PedsQLTM: measurement model for the pediatric quality of life inventory. Medical Care1999;37(2):126‐39. [www.jstor.org/stable/3767218; PUBMED: 10024117] ">PedsQL 1999</a>), the Caregiver Priorities and Child Health Index of Life with Disabilities (<a href="./references#CD012430-bbs2-0027" title="NarayananUG , WeirS , FehlingsDL . Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD©) Questionnaire: manual and interpretation guide. www.sickkids.ca/pdfs/Research/CPChild/6573‐CPCHILD_manual.pdf. (accessed prior to 23 April). ">Narayanan 2007</a>), or other validated scale </p> </li> </ol> </p> <p>We placed no restrictions on length of outcome follow‐up.</p> <p>We used those outcomes marked with an asterisk (*) to populate the 'Summary of findings' table. </p> </section> </section> </section> <section id="CD012430-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <p>This review is based on a published protocol (<a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>). </p> <section id="CD012430-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the electronic databases and trials registers listed below up to May 2017.</p> <p> <ol id="CD012430-list-0003"> <li> <p>Cochrane Register of Studies Online, which includes the Cochrane Developmental, Psychosocial and Learning Problems Group Specialised Register (<a href="http://crso.cochrane.org/" target="_blank">crso.cochrane.org</a>; searched 25 May 2017). </p> </li> <li> <p>MEDLINE Ovid (1946 to May week 3 2017).</p> </li> <li> <p>MEDLINE In‐Process &amp; Other Non‐Indexed Citations Ovid (searched 25 May 2017).</p> </li> <li> <p>MEDLINE Epub Ahead of Print Ovid (searched 25 May 2017).</p> </li> <li> <p>Embase Ovid (1974 to 2017 week 21).</p> </li> <li> <p>CINAHL EBSCOhost (Cumulative Index to Nursing and Allied Health Literature; 1937 to 25 May 2017). </p> </li> <li> <p>Science Citation Index Web of Science (SCI; 1990 to 24 May 2017).</p> </li> <li> <p>Conference Proceedings Citation Index – Science Web of Science (CPCI‐S; 1990 to 24 May 2017). </p> </li> <li> <p>Cochrane Database of Systematic Reviews (CDSR; 2017, Issue 5) part of the Cochrane Library (searched 26 May 2017). </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE; 2015, Issue 2. Final Issue) part of the Cochrane Library (searched 26 May 2017). </p> </li> <li> <p>LILACS (<a href="http://lilacs.bvsalud.org/en/" target="_blank">lilacs.bvsalud.org/en</a>; searched 26 May 2017). </p> </li> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 26 May 2017). </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://who.int/ictrp/en/" target="_blank">who.int/ictrp/en</a>; searched 26 May 2017). </p> </li> </ol> </p> <p>We developed a search strategy in MEDLINE, which we adapted for each of the sources listed above (<a href="./appendices#CD012430-sec-0099">Appendix 1)</a> . We did not apply any date or language restrictions. </p> </section> <section id="CD012430-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of included reports and relevant reviews. In addition, we contacted experts to identify any additional studies not retrieved by our electronic searches. </p> </section> </section> <section id="CD012430-sec-0047"> <h3 class="title" id="CD012430-sec-0047">Data collection and analysis</h3> <p>We were not able to use many of our planned methods because only one study met the criteria for inclusion in the review (<a href="#CD012430-sec-0037">Criteria for considering studies for this review</a>). Details of unused methods can be found in <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a> and <a href="#CD012430-tbl-0002">Table 1</a>. What follows next is a description of methods that we did use. </p> <div class="table" id="CD012430-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Unused methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unused methods</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measures of treatment effect</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Continuous data</b> </p> <p>For continuous outcomes we will calculate the MD and corresponding 95% CI if studies use the same rating scales. We will calculate the SMD with 95% CIs if studies use different scales to measure the same outcomes. </p> <p>As recommended in section 9.4.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), we will focus on final values unless some of the studies use change scores. We will combine studies that report final values with studies that report only change scores in the same meta‐analysis, provided that the studies use the same rating scale. </p> <p>We will conduct the analysis according to age, as children and adults respond differently to medication. We will combine the data from all groups in studies that have trihexyphenidyl in more than one group (i.e. different frequencies) and then separate these when performing the subgroup analysis to see how the different frequencies influence the results (see item four in the <a href="#CD012430-sec-0059">Subgroup analysis and investigation of heterogeneity</a> section). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Multiple outcomes</b> </p> <p>If studies provide multiple, interchangeable measures of the same construct at the same point in time, we will calculate the average SMD across the outcomes and the average estimated variances, as recommended in section 16.1.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0017" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis issues</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cluster‐RCTs</b> </p> <p>If included trials use cluster randomisation, we will extract an ICC and use this to reanalyse the data. Where no ICC is given and a unit of analysis error appears to exist, we will contact the trial authors and ask them to provide either an ICC or the raw data to enable calculation of an ICC. Where no ICC is made available, we will search for similar studies from which we can impute an ICC, or seek statistical advice to obtain an estimate of the ICC. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dealing with missing data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will contact trial investigators to request missing data. If the trialists provide missing data, we will conduct a meta‐analysis according to intention‐to‐treat principles using all data and keeping participants in the treatment group to which they were originally randomised, regardless of the treatment they actually received, as recommended in section 16.1.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0017" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). If missing data are not provided, we will analyse only the available data. If there is concern regarding a high level of missing data, such that data could not be included in a meta‐analysis, we will include a qualitative summary in the text of the review. We will document missing data and attrition in the 'Risk of bias' tables, and we will explore how missing data might affect the interpretation of the results by conducting a sensitivity analysis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of heterogeneity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will assess clinical heterogeneity by comparing the between‐trials distribution of participant characteristics (e.g. children versus adults) and intervention characteristics (e.g. treatment type and dose), and assess methodological heterogeneity by comparing trial characteristics (e.g. cross‐over versus parallel design). We will evaluate statistical heterogeneity using the I<sup>2</sup> statistic and the Chi<sup>2</sup> test of heterogeneity, with statistical significance set at P value &lt; 0.10. As recommended in section 9.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), we will consider I<sup>2</sup> values as follows. </p> <p> <ol id="CD012430-list-0004"> <li> <p>0% to 40% might not be important.</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity.</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity.</p> </li> <li> <p>75% to 100% represents considerable heterogeneity.</p> </li> </ol> </p> <p>We will report Tau<sup>2</sup> as an estimate of the between‐study variance when reporting the results from the random‐effects model. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of reporting biases</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If we identify 10 or more studies, we will use funnel plots to investigate the relationship between intervention effect and study size. We will explore possible reasons for any asymmetry found. We will analyse the funnel plot of the data to ascertain asymmetry. Asymmetry of a funnel plot may indicate, among other things, publication bias or poor methodological quality (<a href="./references#CD012430-bbs2-0010" title="EggerM , Davey‐SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [DOI: 10.1136/bmj.315.7109.629; PMC2127453; PUBMED: 9310563] ">Egger 1997</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Data synthesis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will synthesise results in a meta‐analysis using a fixed‐effect model when studies are similar enough with regard to the intervention, population and methods, to assume that the same treatment effect is estimated. We will synthesise results in a meta‐analysis using a random‐effects model when statistical heterogeneity is found or when studies differ enough with regard to the intervention, population, and methods, to assume that different yet related treatment effects are estimated, and when it is deemed to be clinically relevant, as recommended in section 9.4.3.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct the subgroup analyses listed below.</p> <p> <ol id="CD012430-list-0005"> <li> <p>Classification of cerebral palsy according to motor ability using the Gross Motor Function Classification System.Movement disorder and whether or not there is a mixed pattern (spasticity, dystonia, ataxic, choreoathetoid, hypotonic, mixed). </p> </li> <li> <p>Participant age (e.g. adults versus children, preschool children versus school‐age children). </p> </li> <li> <p>Treatment dosage and frequency of medication (2 versus 3 times a day; and low dose versus high dose). </p> </li> <li> <p>Polypharmacy: whether sole agents or other agents are used (trihexyphenidyl alone versus trihexyphenidyl and another agent). </p> </li> <li> <p>Length of follow‐up (e.g. ≤ 3 months versus &gt; 3 months).</p> </li> </ol> </p> <p>We will also look at the number of participants per study to determine if this is sufficient to perform a subgroup analysis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct sensitivity analyses to investigate the effect on the overall results of excluding trials that meet the criteria described below. </p> <p> <ol id="CD012430-list-0006"> <li> <p>Inadequate allocation concealment or sequence generation (selection bias)</p> </li> <li> <p>No blinding (performance bias)</p> </li> <li> <p>Incomplete outcome data (attrition bias). To investigate the effect of incomplete outcome data we will re‐perform the meta‐analysis including only those studies with high rates of complete data and compare this result to the full meta‐analysis that contains studies with both high and low rates of complete outcome data (i.e. all included studies). In this way we will be able to determine if the results of the full meta‐analysis remain true and have not been influenced by incomplete outcome data. </p> </li> </ol> </p> <p>We will also conduct a sensitivity analysis for studies with very low risk of bias. In addition, we will conduct a sensitivity analysis using a range of ICCs to assess the impact on treatment effect. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI</b> : confidence intervals; <b>ICC</b> : intraclass correlation coefficient; <b>MD</b> : mean difference; <b>SMD</b>: standardised mean difference. </p> </div> </div> <section id="CD012430-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors, ARH and AS, independently screened the titles and abstracts of the citations identified from the search, discarding those that were clearly irrelevant. They then obtained the full texts of those studies that met, or seemed to meet, the inclusion criteria (<a href="#CD012430-sec-0037">Criteria for considering studies for this review</a>), and they assessed them for relevance. KW acted as arbiter in the event of dispute. We recorded our decisions in a PRISMA flow diagram (<a href="./references#CD012430-bbs2-0025" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLOS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097; PMC2707599; PUBMED: 19621072] ">Moher 2009</a>). </p> </section> <section id="CD012430-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (ARH and AS) independently extracted data from the included study using a data extraction form designed and piloted for this review. They extracted the following information. </p> <p> <ol id="CD012430-list-0007"> <li> <p>Study methods and setting: study type (type of RCT), study site, country of publication, language of publication, publication type and study duration. </p> </li> <li> <p>Participant details: age, sex, diagnosis and diagnosis tool.</p> </li> <li> <p>Intervention details: intervention type, including dosage, mode of delivery, frequency and duration; placebo type, including dosage, mode of delivery, frequency and duration. </p> </li> <li> <p>Outcomes: all primary and secondary outcomes (see <a href="#CD012430-sec-0041">Types of outcome measures</a>). </p> </li> </ol> </p> <p>We resolved disagreements through consultation with KW.</p> <p>ARH entered data into Review Manager 5 (RevMan 5), which KW checked for accuracy (<a href="./references#CD012430-bbs2-0033" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagan: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD012430-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ARH and AS) independently assessed the risk of bias in the included study using the tool described in section 8.5.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0018" title="HigginsJPT , AltmanDG , SterneJAC , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook. ">Higgins 2017</a>). For the study, they judged the risk of bias to be either low, high or unclear, for each of the seven domains described in <a href="./appendices#CD012430-sec-0113">Appendix 2</a>. They resolved disagreements by discussion with KW. </p> </section> <section id="CD012430-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012430-sec-0052"> <h5 class="title">Dichotomous data</h5> <p>We had planned to analyse dichotomous outcomes by calculating the odds ratio (OR) and corresponding 95% confidence intervals (CI). However, because adverse effects (the only dichotomous outcome in this review) were frequent in the one included study, we calculated the risk ratio (RR) and corresponding 95% CI to provide a more interpretable statistic. </p> </section> <section id="CD012430-sec-0053"> <h5 class="title">Continuous data</h5> <p>As recommended in section 9.4.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), we performed an ANCOVA to estimate the change score due to the one included study using change scores. A potential problem of including change scores is that the standard deviation of changes may not be reported in the original study (<a href="./references#CD012430-bbs2-0016" title="HigginsJPT , DeeksJJ , editor(s) . Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). </p> <p>See also <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a> and <a href="#CD012430-tbl-0002">Table 1</a>. </p> </section> </section> <section id="CD012430-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <p>The included study was a cross‐over trial, and we used the data from the first period of the cross‐over. We did not include any cluster‐randomised trials (see <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>; <a href="#CD012430-tbl-0002">Table 1</a>). </p> </section> <section id="CD012430-sec-0055"> <h4 class="title">Dealing with missing data</h4> <p>We assessed missing data and dropouts for the included study. We reported the number of participants included in the final analysis as a proportion of all participants in the study, reporting reasons for missing data (dropouts) according to their randomised groups (trihexyphenidyl and placebo) as provided in the study. We examined the differences in these rates to determine the treatment effect bias, as differences in rates of missing data between the groups are indicative of data not missing at random. This would indicate a high risk of bias for incomplete outcome reporting in the included study. This is reported in the risk of bias. </p> </section> <section id="CD012430-sec-0056"> <h4 class="title">Assessment of heterogeneity</h4> <p>We were unable to assess heterogeneity, as we only included one study in the review (see <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>; <a href="#CD012430-tbl-0002">Table 1</a>). </p> </section> <section id="CD012430-sec-0057"> <h4 class="title">Assessment of reporting biases</h4> <p>We were unable to assess reporting biases, as we only included one study in the review (see <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>; <a href="#CD012430-tbl-0002">Table 1</a>). </p> </section> <section id="CD012430-sec-0058"> <h4 class="title">Data synthesis</h4> <p>We were unable to conduct a meta‐analysis as we only included one study in the review (see <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>; <a href="#CD012430-tbl-0002">Table 1</a>). </p> </section> <section id="CD012430-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We were unable to conduct a subgroup analysis or investigate heterogeneity, as we only included one study in the review (see <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>; <a href="#CD012430-tbl-0002">Table 1</a>). </p> </section> <section id="CD012430-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>We were unable to conduct a sensitivity analysis, as we only included one study in the review (see <a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>; <a href="#CD012430-tbl-0002">Table 1</a>). </p> <section id="CD012430-sec-0061"> <h5 class="title">Summary of findings table</h5> <p>Following the recommendations in section 11.5.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0037" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , Guyatt GH on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing 'Summary of findings' tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston M, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook. ">Schünemann 2017</a>), and using GRADEprofiler: Guideline Development Tool (<a href="./references#CD012430-bbs2-0014" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version (accessed prior to 19 April 2018). Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>), we created a 'Summary of findings' table for the comparison, trihexyphenidyl versus placebo for dystonia in cerebral palsy. We reported the following outcomes in the table: change in dystonia; adverse effects; participation in activities of daily living; and quality of life. We reported all outcomes at 12 weeks follow‐up except for adverse effects, whose analysis contains data assessed at both 12 and 28 weeks because we were unable to separate the data. </p> <p>Two review authors (AH and KW) independently assessed the quality of the evidence for each outcome contributing data using the GRADE tool (<a href="./references#CD012430-bbs2-0013" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐8. [DOI: 10.1136/bmj.328.7454.1490; PMC428525; PUBMED: 15205295] ">GRADE 2004</a>), looking at study limitations, consistency of effect, imprecision, indirectness and publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012430-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012430-sec-0062"></div> <section id="CD012430-sec-0063"> <h3 class="title">Description of studies</h3> <p>A description of the included study is in the <a href="./references#CD012430-sec-0128" title="">Characteristics of included studies</a> table. </p> <section id="CD012430-sec-0064"> <h4 class="title">Results of the search</h4> <p>We conducted a literature search up to 26 May 2017, identifying 128 original records. After screening of titles and abstracts, we retrieved three full‐text reports. We excluded one study, <a href="./references#CD012430-bbs2-0002" title="ReddihoughD , JohnsonH , StaplesM , HudsonI , ExarchosH . Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Developmental Medicine &amp; Child Neurology1990;32(11):985‐9. [DOI: 10.1111/j.1469‐8749.1990.tb08121.x; PUBMED: 2269408] ">Reddihough 1990</a>, because it was not an RCT (see <a href="#CD012430-sec-0071">Excluded studies</a>; <a href="./references#CD012430-sec-0129" title="">Characteristics of excluded studies</a> table). We identified two reports of one original trial for inclusion (<a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a>). <a href="#CD012430-fig-0001">Figure 1</a> shows a study flow diagram. </p> <div class="figure" id="CD012430-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012430-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012430-sec-0065"> <h4 class="title">Included studies</h4> <section id="CD012430-sec-0066"> <h5 class="title">Study design</h5> <p><a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> was a randomised, double‐blind, placebo‐controlled, cross‐over trial. </p> </section> <section id="CD012430-sec-0067"> <h5 class="title">Participants</h5> <p>The study recruited 16 children with predominant dystonic cerebral palsy and a mean age of nine years (SD 4.3 years, range 2 to 17 years). There were 10 boys and 6 girls. </p> </section> <section id="CD012430-sec-0068"> <h5 class="title">Diagnosis</h5> <p>One of the study physicians verified the diagnosis of dystonia, but authors did not report the method used. </p> </section> <section id="CD012430-sec-0069"> <h5 class="title">Randomisation</h5> <p>Children were randomised into either trihexyphenidyl (dose starting at 0.2 mg/kg/d in three divided doses and increased over six weeks up to a maximum 2.5 mg/kg/d in three divided doses) or placebo (liquid delivered orally at 2.5 mg/kg/day of liquid in three divided doses (equals same volume as intervention)) for 12 weeks. Parents administered the trihexyphenidyl and the placebo. There was a washout period of four weeks prior to cross‐over. </p> </section> <section id="CD012430-sec-0070"> <h5 class="title">Outcomes</h5> <p>The primary outcomes reported were change in dystonia from baseline, assessed using the Barry Albright Dystonia Scale (BADS) and adverse effects. Authors counted all side effects as adverse effects. Secondary outcomes reported were upper limb function, assessed using the Quality of Upper Extremity Skills Test (QUEST) and participation in activities of daily living at home, school and in the community, assessed using the Canadian Occupational Performance Measure (COPM) and the Goal Attainment Scale (GAS). Trialists did not measure pain or quality of life. Children were assessed at baseline, 12 weeks and 28 weeks after commencement. We only included data from the first phase (12 weeks) in this review, except for adverse effects where it was not possible to separate first‐ and second‐phase data. </p> </section> </section> <section id="CD012430-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded one study, <a href="./references#CD012430-bbs2-0002" title="ReddihoughD , JohnsonH , StaplesM , HudsonI , ExarchosH . Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Developmental Medicine &amp; Child Neurology1990;32(11):985‐9. [DOI: 10.1111/j.1469‐8749.1990.tb08121.x; PUBMED: 2269408] ">Reddihough 1990</a>, because it was not an RCT. See the <a href="./references#CD012430-sec-0129" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD012430-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD012430-fig-0002">Figure 2</a> presents a summary of the 'Risk of bias' assessment for the included trial, <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a>. We judged the trial as being at low risk of bias for all categories. </p> <div class="figure" id="CD012430-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012430-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012430-sec-0073"> <h4 class="title">Allocation</h4> <p>We considered <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> to be at low risk of selection bias due to both random sequence generation and allocation concealment because the trial pharmacy generated a randomisation table and kept codes concealed until after data collection was complete. </p> </section> <section id="CD012430-sec-0074"> <h4 class="title">Blinding</h4> <p>We judged <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> to be at low risk of performance and detection bias because assessors, the patient and the family were all blinded to the intervention. </p> </section> <section id="CD012430-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>We judged <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> to be at low risk of attrition bias because, although two of the eight children who received the active treatment in the first phase dropped out, one child withdrew due to a family crisis unrelated to the medication. </p> </section> <section id="CD012430-sec-0076"> <h4 class="title">Selective reporting</h4> <p>We judged <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> to be at low risk of reporting bias because it reported on all pre‐specified outcomes. </p> </section> <section id="CD012430-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>We identified no other potential sources of bias for <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a>. </p> </section> </section> <section id="CD012430-sec-0078"> <h3 class="title" id="CD012430-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD012430-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings: Trihexyphenidyl compared with placebo for dystonia in cerebral palsy</a> </p> <p>In order to obtain the first‐phase data only, we contacted the study authors and they provided the requested information. The follow‐up time point for the first phase was 12 weeks. </p> <section id="CD012430-sec-0079"> <h4 class="title">Primary outcomes</h4> <section id="CD012430-sec-0080"> <h5 class="title">Change in dystonia from baseline</h5> <p>Our analysis of first‐phase data only showed no evidence of a difference in mean follow‐up scores, with an estimate that the BADS score (eight body regions assessed for dystonia on a five‐point scale (0 = none to 4 = severe), for a total score of 0 to 32) was 2.67 points higher (95% CI −2.55 to 7.90; low‐quality evidence; <a href="#CD012430-fig-0003">Figure 3</a>), that is, worse dystonia, in the treated group. </p> <div class="figure" id="CD012430-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="ANCOVA analyses, page 1" data-id="CD012430-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>ANCOVA analyses, page 1</p> </div> </div> </div> <p>The results reported by the study authors from both phases using the general linear model analysis showed no evidence that trihexyphenidyl had any treatment (F<sub>(1,12)</sub> = 0.2, P = 0.67), carry‐over (F<sub>(1,12)</sub> = 1.7, P = 0.22) or order (F<sub>(1,12)</sub> = 0.3, P = 0.57) effects. </p> </section> <section id="CD012430-sec-0081"> <h5 class="title">Adverse effects</h5> <p>The study authors reported that trihexyphenidyl increased the risk of adverse effects by 154% using data from both the first and second phases of the study. All children had reported adverse effects in the treatment phase (16/16), so all children receiving treatment in the first phase experienced adverse effects (8/8). Reported adverse effects included agitation, constipation, dry mouth and poor sleep. Authors reported that 6 out of 16 participants had adverse effects in the placebo phase; however, the timing of these effects is not clear. It is conceivable that children who received the placebo in the second phase may have experienced ongoing adverse effects related to the treatment phase.Therefore, the estimate of the number of adverse effects with placebo in the first phase may be lower than three out of eight, and we may be underestimating the increased risk with treatment. </p> </section> </section> <section id="CD012430-sec-0082"> <h4 class="title">Secondary outcomes</h4> <section id="CD012430-sec-0083"> <h5 class="title">Activity</h5> <p>Our analysis of first‐phase data only showed no evidence of a difference in mean follow‐up scores as measured by the QUEST (36 items across four domains, scored one or two, producing a score of 0 to 100), with an estimated score of 4.62 points lower (95% CI −10.98 to 20.22; low‐quality evidence), that is worse upper limb function, in the treated group. </p> <p>The results reported by the study authors from both phases using general linear model analysis showed no evidence that trihexyphenidyl had any treatment (F<sub>(1,12)</sub> = 0.9, P = 0.37), carry‐over (F<sub>(1,12)</sub> = 1.4, P = 0.25) or order (F<sub>(1,12)</sub> = 0.2, P = 0.90) effects. </p> </section> <section id="CD012430-sec-0084"> <h5 class="title">Participation in activities of daily living</h5> <p>Our analysis of first‐phase data only showed a difference in mean follow‐up scores, as measured by three tools, in the treated group, with an estimate of: 18.86 points higher (95% CI 5.68 to 32.03; low‐quality evidence) for the GAS (up to five functional goals scored on 5‐point scale (−2 = much less than expected to +2 = much more than expected)), 2.91 points higher (95% CI 1.01 to 4.82; low‐quality evidence) for the satisfaction subscale of the COPM (satisfaction with performance in up to five problem areas scored on a 10‐point scale (1 = not satisfied at all to 10 = extremely satisfied)), and 2.24 points higher (CI 95% 0.64 to 3.84; low‐quality evidence; <a href="#CD012430-fig-0004">Figure 4</a>) for the performance subscale of the COPM (performance in up to five problem areas scored on a 10‐point scale (1 = not able to do to 10 = able to do extremely well)). Higher scores represent improved participation. </p> <div class="figure" id="CD012430-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="ANCOVA analyses, page 2" data-id="CD012430-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>ANCOVA analyses, page 2</p> </div> </div> </div> <p>The results reported by the study authors from both phases using general linear model analysis showed no evidence that trihexyphenidyl had any treatment or carry‐over effects for any of the three participation measures but had statistically significant order effects on the GAS (F<sub>(1,11)</sub> = 10.2, P = 0.009) and borderline significant order effects on the performance component of the COPM (F<sub>(1,12)</sub> = 4.7, P = 0.05). </p> </section> <section id="CD012430-sec-0085"> <h5 class="title">Pain and quality of life</h5> <p><a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> did not report on these outcomes. </p> </section> </section> <section id="CD012430-sec-0086"> <h4 class="title">Quality of the evidence</h4> <p>Although we judged <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a> to be at low risk of bias in all categories, we considered the quality of the evidence for all reported outcomes to be low after downgrading two levels due to imprecision resulting from the inclusion of a single small study. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012430-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012430-sec-0087">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012430-sec-0162">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012430-sec-0087"></div> <section id="CD012430-sec-0088"> <h3 class="title" id="CD012430-sec-0088">Summary of main results</h3> <p>For our primary outcomes, the results of our analysis using phase‐one data only from the one included cross‐over trial did not generate evidence that trihexyphenidyl reduces dystonia but did identify that the risk of adverse effects is high. For the secondary outcomes, there was no evidence that trihexyphenidyl increases upper limb function, but there was improved goal attainment relating to improved participation in activities of daily living. There was a lack of internal consistency with the expectation that improvement in goal attainment and participation would be mediated by reduced dystonia. The study did not measure pain or quality of life. </p> <p>The risk for adverse effects needs to be interpreted with caution, as we were unable to separate out first‐ and second‐phase data. Consequently, we may have underestimated the risk for adverse effects with treatment. </p> <p>There were slight differences in the results from our analyses using phase‐one data only compared with the published authors' analyses of combined phases. Using the phase‐one data, we observed differences between the treatment and placebo scores that were in the same direction as the published authors’ analyses, but greater in magnitude. In addition, our results found a difference in COPM performance and satisfaction scales compared to the study authors. This suggests that the magnitude of the treatment effect was smaller in the second phase than in the first phase of the trial. It is not possible to determine whether this difference between analyses is due to small carry‐over effects, to chance or to the small numbers of participants in the trial. </p> </section> <section id="CD012430-sec-0089"> <h3 class="title" id="CD012430-sec-0089">Overall completeness and applicability of evidence</h3> <p>The evidence base for trihexyphenidyl in managing dystonia in people with cerebral palsy is incomplete. The only RCT we could find assessed the outcomes of dystonia reduction, adverse effects, upper limb function and goal attainment related to improved function and participation in a small sample of children and young people aged 2 to 17 years, who either walk with assistive devices or are non‐ambulant. No RCTs have evaluated pain, quality of life, or outcomes for adults with dystonic cerebral palsy or higher gross motor function. </p> </section> <section id="CD012430-sec-0090"> <h3 class="title" id="CD012430-sec-0090">Quality of the evidence</h3> <p>Using the GRADE criteria (<a href="./references#CD012430-bbs2-0013" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐8. [DOI: 10.1136/bmj.328.7454.1490; PMC428525; PUBMED: 15205295] ">GRADE 2004</a>; <a href="./references#CD012430-bbs2-0037" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , Guyatt GH on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing 'Summary of findings' tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston M, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook. ">Schünemann 2017</a>), we rated the quality of the evidence for all outcomes as low, due to the small sample size and lack of any other RCT, leading to imprecision and inconsistency. Consequently, our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </section> <section id="CD012430-sec-0091"> <h3 class="title" id="CD012430-sec-0091">Potential biases in the review process</h3> <p>We conducted an extensive search of all available literature, including grey literature. We included trials regardless of publication date or language. Therefore, we are confident that this review includes all published evidence from RCTs on this topic to date. By including only RCTs, we excluded a small number of non‐randomised studies that examine trihexyphenidyl in cerebral palsy; however, these studies do not add to the quality of evidence for this intervention. One author of this review (DSR) is a co‐author of a published study that we excluded from the review, and three review authors (AH, AS and DSR) collaborate with authors of the included published trial. Independent review authors assessed the eligibility, risk of bias and quality of the evidence for this study. </p> </section> <section id="CD012430-sec-0092"> <h3 class="title" id="CD012430-sec-0092">Agreements and disagreements with other studies or reviews</h3> <p>There is little literature with which to compare the results of this review. Our results are consistent with a recent systematic review of the efficacy of oral pharmacological treatments in dyskinetic cerebral palsy. That review also included the study by <a href="./references#CD012430-bbs2-0001" title="RiceJ , WaughM‐C . Pilot study of trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. Journal of Child Neurology2009;24(2):176‐82. [DOI: 10.1177/0883073808322668; PUBMED: 19182155] RiceJ , WaughM‐C . Trihexyphenidyl in the treatment of dystonic cerebral palsy: a pilot randomized controlled trial. Developmental Medicine &amp; Child Neurology2006;48(106 Suppl):12‐13. [onlinelibrary.wiley.com/doi/epdf/10.1111/j.1469‐8749.2006.tb12591.x] ">Rice 2009</a>, which met our eligibility criteria (<a href="#CD012430-sec-0037">Criteria for considering studies for this review</a>), concluding that "trihexyphenidyl needs further investigation, primarily in dystonic patients with predominant involvement of upper limb" (<a href="./references#CD012430-bbs2-0024" title="MassonR , PaglianoE , BaranelloG . Efficacy of oral pharmacological treatments in dyskinetic cerebral palsy: a systematic review. Developmental Medicine &amp; Child Neurology2017;59(12):1237‐48. [DOI: 10.1111/dmcn.13532; PUBMED: 28872668] ">Masson 2017</a>). </p> <p>Other non‐randomised studies have reported inconsistent results from studies examining trihexyphenidyl in cerebral palsy. In contrast to our review, a prospective, open‐label, multicentre pilot trial of high‐dose trihexyphenidyl in 23 children aged 4 to 15 years with cerebral palsy and dystonia impairing function in the dominant upper extremity found some improvement in upper limb function (<a href="./references#CD012430-bbs2-0036" title="SangerTD , BastianA , BrunstromJ , DamianoD , DelgadoM , Dure , L , et al. Prospective open‐label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. Journal of Child Neurology2007;22(5):530‐7. [DOI: 10.1177/0883073807302601; PUBMED: 17690057] ">Sanger 2007</a>). However post hoc analyses indicated that a subgroup of children with hyperkinetic dystonia worsened over this period. Similar to our review, <a href="./references#CD012430-bbs2-0036" title="SangerTD , BastianA , BrunstromJ , DamianoD , DelgadoM , Dure , L , et al. Prospective open‐label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. Journal of Child Neurology2007;22(5):530‐7. [DOI: 10.1177/0883073807302601; PUBMED: 17690057] ">Sanger 2007</a> reported no effect for reducing dystonia or improving gross motor function, quality of life, or care and comfort. Retrospective chart reviews have reported results inconsistent with ours: <a href="./references#CD012430-bbs2-0008" title="Carranza‐del RioJ , CleggNJ , MooreA , DelgadoMR . Use of trihexyphenidyl in children with cerebral palsy. Pediatric Neurology2011;44(3):202‐6. [DOI: 10.1016/j.pediatrneurol.2010.09.008; PUBMED: 21310336] ">Carranza del Rio 2011</a> reported reduction of dystonia, and <a href="./references#CD012430-bbs2-0007" title="Ben‐PaziH . Trihexyphenidyl improves motor function in children with dystonic cerebral palsy: a retrospective analysis. Journal of Child Neurology2011;26(7):810‐6. [DOI: 10.1177/0883073810392582; PUBMED: 21498790] ">Ben‐Pazi 2011</a> and <a href="./references#CD012430-bbs2-0020" title="HoonAHJr , FreesePO , ReinhardtEM , WilsonMA , LawrieWTJr , HarrymanSE , et al. Age‐dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatric Neurology2001;25(1):55‐58. [PUBMED: 11483397] ">Hoon 2001</a>, improvements in motor function; however, methodological issues and inconsistent outcome reporting lower the quality of these results. Also, higher positive outcomes can be expected when using retrospective data. Although these non‐randomised studies add to the body of literature for trihexyphenidyl in dystonia in cerebral palsy, their results need to be interpreted with caution due to the low quality of the evidence. </p> <p>Consistent with our review, all studies reported a high incidence of adverse effects.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012430-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/urn:x-wiley:14651858:media:CD012430:CD012430-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_t/tCD012430-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012430-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012430-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/urn:x-wiley:14651858:media:CD012430:CD012430-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_t/tCD012430-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012430-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012430-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/urn:x-wiley:14651858:media:CD012430:CD012430-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_t/tCD012430-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="ANCOVA analyses, page 1" data-id="CD012430-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>ANCOVA analyses, page 1</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012430-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/urn:x-wiley:14651858:media:CD012430:CD012430-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_t/tCD012430-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="ANCOVA analyses, page 2" data-id="CD012430-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>ANCOVA analyses, page 2</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012430-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/urn:x-wiley:14651858:media:CD012430:CD012430-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_t/tCD012430-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Trihexphenidyl versus placebo, Outcome 1 Adverse effects." data-id="CD012430-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Trihexphenidyl versus placebo, Outcome 1 Adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/references#CD012430-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/media/CDSR/CD012430/image_n/nCD012430-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012430-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: Trihexyphenidyl compared with placebo for dystonia in cerebral palsy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Trihexyphenidyl compared with placebo for dystonia in cerebral palsy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population</b>: children with dystonic cerebral palsy </p> <p><b>Settings</b>: one tertiary care hospital </p> <p><b>Intervention</b>: trihexyphenidyl </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Trihexyphenidyl</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in dystonia from baseline</b> </p> <p>Measured by: BADS (eight body regions assessed for dystonia on a five‐point scale (0 = none to 4 = severe), minimum score 0 to maximum score 32; higher score = greater severity of dystonia) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 15.50 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was <b>2.67 points higher</b> (2.55 lower to 7.90 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects<sup>b</sup> (mood disturbance, irritability, behavioural change, constipation)</b> </p> <p>Measured by: counts of number and type</p> <p>Follow‐up: various (includes data assessed at both 12 and 28 weeks)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.54 (1.38 to 4.67)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participation in activities of daily living</b> :<b>individual goal setting</b> </p> <p>Measured by: GAS (up to 5 functional goals scored on a 5‐point scale (−2 = much less than expected to +2 = much more than expected); higher score = better than expected outcome) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 27.63 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was <b>18.86 points higher</b> (5.68 higher to 32.03 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participation in activities of daily living</b> :<b>satisfaction with individual goals</b> </p> <p>Measured by: satisfaction subscale of the COPM (satisfaction with performance in up to 5 problem areas scored on a 10‐point scale (1 = not satisfied at all to 10 = extremely satisfied); higher score = greater satisfaction) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 2.96 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was <b>2.91 points higher</b> (1.01 higher to 4.82 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participation in activities of daily living</b> :<b>performance of individual goals</b> </p> <p>Measured by: performance subscale of the COPM (up to five problem areas scored on a 10‐point scale (1 = not able to do to 10 = able to do extremely well; higher score = better performance) </p> <p>Follow‐up: 12 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the control group was 3.14 points</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean follow‐up score in the intervention group was<b>2.24 points higher</b> (0.64 higher to 3.84 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> 1 (RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low<sup>a</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in the footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>BADS</b> : Barry Albright Dystonia Scale; <b>CI</b> : Confidence interval; <b>COPM</b> : Canadian Occupational Performance Measure; <b>GAS</b> : Goal Attainment Scale; <b>RCT</b> : randomised controlled trial; <b>RR</b>: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality</b> : we are very confident that the true effect lies close to that of the estimate of effect<br/> <b>Moderate quality</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of effect, but there is a possibility that it is substantially different<br/> <b>Low quality</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of effect<br/> <b>Very low quality</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to imprecision; small sample size from one study only.<br/> <sup>b</sup>All side effects were counted as adverse effects, as defined in our protocol (<a href="./references#CD012430-bbs2-0043" title="BakerLB , HarveyAR , EgbertsKJ , ReddihoughDS , ScheinbergA , WilliamsK . Trihexyphenidyl for dystonia in cerebral palsy. Cochrane Database of Systematic Reviews2016, Issue 11. [DOI: 10.1002/14651858.CD012430] ">Baker 2017</a>). Adverse effect data was from both phases. It was not possible to obtain adverse effect data from the first phase only. All children were reported to have adverse effects in the treatment phase. Six out of 16 participants were reported to have adverse effects in the placebo phase; however, the timing of these is not clear. The estimated number of adverse effects in the placebo phase may therefore be lower and we may be underestimating the relative risk. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: Trihexyphenidyl compared with placebo for dystonia in cerebral palsy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012430-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Unused methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Method</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unused methods</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Measures of treatment effect</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Continuous data</b> </p> <p>For continuous outcomes we will calculate the MD and corresponding 95% CI if studies use the same rating scales. We will calculate the SMD with 95% CIs if studies use different scales to measure the same outcomes. </p> <p>As recommended in section 9.4.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), we will focus on final values unless some of the studies use change scores. We will combine studies that report final values with studies that report only change scores in the same meta‐analysis, provided that the studies use the same rating scale. </p> <p>We will conduct the analysis according to age, as children and adults respond differently to medication. We will combine the data from all groups in studies that have trihexyphenidyl in more than one group (i.e. different frequencies) and then separate these when performing the subgroup analysis to see how the different frequencies influence the results (see item four in the <a href="#CD012430-sec-0059">Subgroup analysis and investigation of heterogeneity</a> section). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Multiple outcomes</b> </p> <p>If studies provide multiple, interchangeable measures of the same construct at the same point in time, we will calculate the average SMD across the outcomes and the average estimated variances, as recommended in section 16.1.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0017" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unit of analysis issues</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cluster‐RCTs</b> </p> <p>If included trials use cluster randomisation, we will extract an ICC and use this to reanalyse the data. Where no ICC is given and a unit of analysis error appears to exist, we will contact the trial authors and ask them to provide either an ICC or the raw data to enable calculation of an ICC. Where no ICC is made available, we will search for similar studies from which we can impute an ICC, or seek statistical advice to obtain an estimate of the ICC. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Dealing with missing data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will contact trial investigators to request missing data. If the trialists provide missing data, we will conduct a meta‐analysis according to intention‐to‐treat principles using all data and keeping participants in the treatment group to which they were originally randomised, regardless of the treatment they actually received, as recommended in section 16.1.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0017" title="HigginsJPT , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). If missing data are not provided, we will analyse only the available data. If there is concern regarding a high level of missing data, such that data could not be included in a meta‐analysis, we will include a qualitative summary in the text of the review. We will document missing data and attrition in the 'Risk of bias' tables, and we will explore how missing data might affect the interpretation of the results by conducting a sensitivity analysis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of heterogeneity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will assess clinical heterogeneity by comparing the between‐trials distribution of participant characteristics (e.g. children versus adults) and intervention characteristics (e.g. treatment type and dose), and assess methodological heterogeneity by comparing trial characteristics (e.g. cross‐over versus parallel design). We will evaluate statistical heterogeneity using the I<sup>2</sup> statistic and the Chi<sup>2</sup> test of heterogeneity, with statistical significance set at P value &lt; 0.10. As recommended in section 9.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>), we will consider I<sup>2</sup> values as follows. </p> <p> <ol id="CD012430-list-0004"> <li> <p>0% to 40% might not be important.</p> </li> <li> <p>30% to 60% may represent moderate heterogeneity.</p> </li> <li> <p>50% to 90% may represent substantial heterogeneity.</p> </li> <li> <p>75% to 100% represents considerable heterogeneity.</p> </li> </ol> </p> <p>We will report Tau<sup>2</sup> as an estimate of the between‐study variance when reporting the results from the random‐effects model. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Assessment of reporting biases</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If we identify 10 or more studies, we will use funnel plots to investigate the relationship between intervention effect and study size. We will explore possible reasons for any asymmetry found. We will analyse the funnel plot of the data to ascertain asymmetry. Asymmetry of a funnel plot may indicate, among other things, publication bias or poor methodological quality (<a href="./references#CD012430-bbs2-0010" title="EggerM , Davey‐SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [DOI: 10.1136/bmj.315.7109.629; PMC2127453; PUBMED: 9310563] ">Egger 1997</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Data synthesis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will synthesise results in a meta‐analysis using a fixed‐effect model when studies are similar enough with regard to the intervention, population and methods, to assume that the same treatment effect is estimated. We will synthesise results in a meta‐analysis using a random‐effects model when statistical heterogeneity is found or when studies differ enough with regard to the intervention, population, and methods, to assume that different yet related treatment effects are estimated, and when it is deemed to be clinically relevant, as recommended in section 9.4.3.1 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012430-bbs2-0009" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MC, editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a>). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct the subgroup analyses listed below.</p> <p> <ol id="CD012430-list-0005"> <li> <p>Classification of cerebral palsy according to motor ability using the Gross Motor Function Classification System.Movement disorder and whether or not there is a mixed pattern (spasticity, dystonia, ataxic, choreoathetoid, hypotonic, mixed). </p> </li> <li> <p>Participant age (e.g. adults versus children, preschool children versus school‐age children). </p> </li> <li> <p>Treatment dosage and frequency of medication (2 versus 3 times a day; and low dose versus high dose). </p> </li> <li> <p>Polypharmacy: whether sole agents or other agents are used (trihexyphenidyl alone versus trihexyphenidyl and another agent). </p> </li> <li> <p>Length of follow‐up (e.g. ≤ 3 months versus &gt; 3 months).</p> </li> </ol> </p> <p>We will also look at the number of participants per study to determine if this is sufficient to perform a subgroup analysis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We will conduct sensitivity analyses to investigate the effect on the overall results of excluding trials that meet the criteria described below. </p> <p> <ol id="CD012430-list-0006"> <li> <p>Inadequate allocation concealment or sequence generation (selection bias)</p> </li> <li> <p>No blinding (performance bias)</p> </li> <li> <p>Incomplete outcome data (attrition bias). To investigate the effect of incomplete outcome data we will re‐perform the meta‐analysis including only those studies with high rates of complete data and compare this result to the full meta‐analysis that contains studies with both high and low rates of complete outcome data (i.e. all included studies). In this way we will be able to determine if the results of the full meta‐analysis remain true and have not been influenced by incomplete outcome data. </p> </li> </ol> </p> <p>We will also conduct a sensitivity analysis for studies with very low risk of bias. In addition, we will conduct a sensitivity analysis using a range of ICCs to assess the impact on treatment effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><b>CI</b> : confidence intervals; <b>ICC</b> : intraclass correlation coefficient; <b>MD</b> : mean difference; <b>SMD</b>: standardised mean difference. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Unused methods</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/full#CD012430-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012430-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Trihexphenidyl versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Trihexphenidyl versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012430.pub2/references#CD012430-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012430.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012430-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012430-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012430-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012430-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012430-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012430-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012430\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012430\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012430\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012430\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012430\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=4nUWI3Cc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012430.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012430.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012430.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012430.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012430.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718040646"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012430.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718040650"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012430.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc6a19acef49c',t:'MTc0MDcxODA0MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 